Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents
Document/Exhibit Description Pages Size
1: 10-K Form 10-K for Year Ended December 31, 2011 HTML 1.20M
2: EX-3.1 Amended and Restated Certificate of Incorporation HTML 61K
of Cytrx Corporation, as Amended
4: EX-10.12 Third Amendment to Third Amended and Restated HTML 18K
Employment Agreement, Dated January 1, 2012,
Between Cytrx Corporation and Steven A. Kriegsman
5: EX-10.20 Employment Agreement Dated January 1, 2012 Between HTML 72K
Cytrx Corporation and Daniel Levitt, M.D., Ph.D.
6: EX-10.21 Employment Agreement Dated January 1, 2012, HTML 59K
Between Cytrx Corporation and Scott Geyer
7: EX-10.22 Employment Agreement Dated January 1, 2012, HTML 61K
Between Cytrx Corporation and Benjamin S. Levin
8: EX-10.23 Employment Agreement Dated January 1, 2012, HTML 61K
Between Cytrx Corporation and Scott Wieland
9: EX-10.24 Employment Agreement Dated January 1, 2012, HTML 60K
Between Cytrx Corporation and John Y. Caloz
10: EX-10.26 Investment Banking Agreement Dated February 14, HTML 58K
2012, Between Cytrx Corporation and Legend
Securities, Inc.
3: EX-10.6 Cytrx Corporation Amended and Restated 2008 Stock HTML 87K
Incentive Plan
11: EX-23.1 Consent of Bdo Usa, LLP HTML 17K
12: EX-31.1 Certification -- §302 - SOA'02 HTML 22K
13: EX-31.2 Certification -- §302 - SOA'02 HTML 22K
14: EX-32.1 Certification -- §906 - SOA'02 HTML 18K
15: EX-32.2 Certification -- §906 - SOA'02 HTML 18K
34: R1 Document And Entity Information HTML 44K
27: R2 Consolidated Balance Sheets HTML 118K
32: R3 Consolidated Balance Sheets (Parenthetical) HTML 45K
36: R4 Consolidated Statements of Operations HTML 78K
47: R5 Consolidated Statements of Stockholders' Equity HTML 73K
28: R6 Consolidated Statements of Cash Flows HTML 142K
31: R7 Nature of Business HTML 23K
26: R8 Summary of Significant Accounting Policies HTML 73K
24: R9 Recent Accounting Pronouncements HTML 24K
48: R10 Receivable HTML 19K
38: R11 Prepaid and Other Assets HTML 18K
37: R12 Marketable securities HTML 21K
42: R13 Equipment and Furnishings HTML 28K
43: R14 Accrued Expenses and Other Current Liabilities HTML 29K
41: R15 Warrant Liabilities HTML 18K
44: R16 Commitments and Contingencies HTML 50K
33: R17 Equity Transactions HTML 31K
35: R18 Investments in RXi and ADVENTRX Pharmaceuticals HTML 24K
40: R19 Stock Options and Warrants HTML 254K
50: R20 Sale of Assets HTML 19K
45: R21 ALSCRT Amendment HTML 18K
29: R22 Stockholder Protection Rights Plan HTML 21K
39: R23 Income Taxes HTML 62K
30: R24 Quarterly Financial Data (Unaudited) HTML 55K
23: R25 Subsequent Events HTML 20K
46: R26 Schedule II Valuation and Qualifying Accounts HTML 38K
49: XML IDEA XML File -- Filing Summary XML 54K
25: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 565K
16: EX-101.INS XBRL Instance -- cytr-20111231 XML 784K
18: EX-101.CAL XBRL Calculations -- cytr-20111231_cal XML 120K
19: EX-101.DEF XBRL Definitions -- cytr-20111231_def XML 76K
20: EX-101.LAB XBRL Labels -- cytr-20111231_lab XML 498K
21: EX-101.PRE XBRL Presentations -- cytr-20111231_pre XML 273K
17: EX-101.SCH XBRL Schema -- cytr-20111231 XSD 60K
22: ZIP XBRL Zipped Folder -- 0000799698-12-000009-xbrl Zip 70K
‘EX-32.1’ — Certification — §906 – SOA’02
This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]
Certification of Chief Executive Officer
Pursuant to 18 U.S.C. 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of CytRx Corporation (the “Company”) hereby certifies that:
(i) the accompanying Annual Report on Form 10-K of the Company for the year ended December 31, 2011 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
By:
|
|
|
| |
|
|
|
| |
|
Chief Executive Officer
|
|
| |
|
|
|
A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 (Section 906), or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to CytRx Corporation and will be retained by CytRx Corporation and furnished to the Securities and Exchange Commission or its staff upon request.
The foregoing certification is being furnished to the Securities and Exchange Commission as an Exhibit to the Form 10-K and shall not be considered filed as part of the Form 10-K.
